[Association between clinical outcome and gene mutation in children with Fanconi anemia].

Li-Xian Chang,Ruan-Ruan Ren,Wen-Yu Yang,Jia-Yuan Zhang,Yang Wan,Tian-Feng Liu,Li Zhang,Xiao-Juan Chen,Shuai Zhu,Min Ruan,Xia Chen,Xiao-Ming Liu,Ben-Quan Qi,Ran-Ran Zhang,Yao Zou,Yu-Mei Chen,Xiao-Fan Zhu

DOI: https://doi.org/10.7499/j.issn.1008-8830.2016.08.014

2016-01-01

Abstract:OBJECTIVE:To investigate the association between clinical outcome and gene mutations in children with Fanconi anemia (FA). METHODS:A retrospective analysis was performed for the clinical data of six children with the same severity of FA and receiving the same treatment. At first, single cell gel electrophoresis and chromosome breakage induced by mitomycin C were performed for diagnosis. Then the gene detection kit for congenital bone marrow failure diseases or complementation test was used for genotyping of FA. Finally the association between the clinical outcome at 3, 6, 9, or 12 months after treatment and gene mutation was analyzed. RESULTS:Of all the six FA children, five had FANCA type disease, and one had FANCM type disease; four children carried two or more FA gene mutations. Among the children with the same severity of FA, those with more FA mutations had a younger age of onset and poorer response to medication, and tended to progress to a severe type. CONCLUSIONS:Children carrying more than two FA mutations have a poor clinical outcome, and hematopoietic stem cell transplantation should be performed as soon as possible.